GGrantIndex
← Leaderboards

Kevin C Ess

Vanderbilt University

$5,903,437
Attributed
$11,640,981
Total exposure
6
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200724
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$11,640,981 · 6

By mechanism

UH3$4,598,859 · 1
R01$3,744,675 · 2
UG3$2,454,302 · 1
K08$828,145 · 1
R13$15,000 · 1

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Brain

Research focus

BrainEpilepsyNeuronsCellsTuberous Sclerosis Protein ComplexIn VitroStem CellsSignal TransductionBrain NeoplasmsNerve Stem CellFutureGenesTsc1 GenePhosphotransferasesTsc2 GeneCortical MalformationInduced Pluripotent Stem CellNeurogliaSignal PathwayPathogenesisComplexProgramsAffectFrap1 Gene

Grant awards (25)

Identifying mTOR Dependent Periods During Brain Development$202,240
R01 · FY2024 · NS
Identifying mTOR Dependent Periods During Brain Development$166,315
R01 · FY2024 · NS
Identifying mTOR Dependent Periods During Brain Development$383,256
R01 · FY2023 · NS
Identifying mTOR Dependent Periods During Brain Development$383,208
R01 · FY2022 · NS
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models$1,149,180
UH3 · FY2021 · TR
Identifying mTOR Dependent Periods During Brain Development$451,615
R01 · FY2021 · NS
Identifying mTOR Dependent Periods During Brain Development$66,684
R01 · FY2021 · NS
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models$1,149,938
UH3 · FY2020 · TR
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models$1,142,940
UH3 · FY2020 · TR
Identifying mTOR Dependent Periods During Brain Development$397,556
R01 · FY2020 · NS
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models$1,156,801
UH3 · FY2019 · TR
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models$1,046,419
UG3 · FY2018 · TR
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models$261,603
UG3 · FY2018 · TR
7th Symposium on ATP1A3 function in health and disease$15,000
R13 · FY2018 · NS
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models$1,146,280
UG3 · FY2017 · TR
Regulation of Neurogenesis in TSC by mTORC1 and mTORC2$345,321
R01 · FY2016 · NS · contact PI
Regulation of Neurogenesis in TSC by mTORC1 and mTORC2$340,956
R01 · FY2015 · NS · contact PI
Regulation of Neurogenesis in TSC by mTORC1 and mTORC2$337,545
R01 · FY2014 · NS · contact PI
Regulation of Neurogenesis in TSC by mTORC1 and mTORC2$329,023
R01 · FY2013 · NS · contact PI
Regulation of Neurogenesis in TSC by mTORC1 and mTORC2$340,956
R01 · FY2012 · NS · contact PI
The Role of TSC Genes During Brain Development$165,629
K08 · FY2011 · NS · contact PI
The Role of TSC Genes During Brain Development$165,629
K08 · FY2010 · NS · contact PI
The Role of TSC Genes During Brain Development$165,629
K08 · FY2009 · NS · contact PI
The Role of TSC Genes During Brain Development$165,629
K08 · FY2008 · NS · contact PI
The Role of TSC Genes During Brain Development$165,629
K08 · FY2007 · NS · contact PI